eptinezumabgalcanezumaberenumabmigraineanti-CGRP therapies
…frequent for erenumab (31%), followed by galcanezumab (27%) and eptinezumab (15%).Conclusion and Relevance Treatment effectiveness was obse…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 138 of 876voriconazoletertiary level hospitalinflammationinflammatory processes
…here may be situations of intoxication by certain drugs such as voriconazole.Aim and Objectives To analyse the influence between C-reactive …
paclitaxelEpirubicinepirubicin-cyclophosphamidePbreast cancertertiary hospital
…eekly P due to intolerance and eleven patients did not complete paclitaxel: four due to severe infusional reaction, two due to myelotoxici…
BaricitinibtofacitinibupadacitinibAbrocitinibADatopic dermatitiscardiac disorders
… JAK inhibitors-related AERs extracted from the FAERS database. Baricitinib was associated with an elevated risk of cardiac disorders (ROR=…
metamizoleMetamizole-associatedMetamizole-induceddipyroneagranulocytosis
…heva D, et al. Genetic factors and risk of agranulocytosis from metamizole. Pharmacogenetics. 1996;6:67–72.4. Shah RR. Metamizole-induced …
proton pump inhibitorsvitaminsPIMsComprehensive Pharmacotherapy Assessment ProgramCPAPtertiary hospitalCPAPComplex chronic patients
…Pharmacotherapeutic group most frequently associated with PIMs: proton pump inhibitors 64 (11.7%) and vitamins 49 (9.0%).Conclusion and Relevance Near…
glimepiridegliclazideglyburidemetforminbiguanidediabetesnon-communicable diseases
…ide (metformin) and three sulfonylureas (glyburide, gliclazide, glimepiride). Drugs were collected from licensed pharmacies and street mark…
afliberceptAFL-8faricimabneovascular age-related macular degenerationdiabetic macular oedemaComisión Interministerial de Precios de MedicamentosnAMDDME
…f aflibercept 8 mg (AFL-8) compared to faricimab 6 mg (FAR) and aflibercept 2 mg (AFL-2).Material and Methods Clinical trial data of phase …
NTZnatalizumabADAbmultiple sclerosisOslo University HospitalpwMS
…University Hospital were switched from originator to biosimilar NTZ. We prospectively evaluated disease activity, safety, serum dru…
ursodeoxycholic acid (UDCA)obeticholic acid (OCA)UDCAOCAPrimary biliary cholangitis (PBC)PBCLondon – Riverside Research Ethics Committee
…atment approach is a step-up model, wherein first-line therapy, ursodeoxycholic acid (UDCA), is given for a minimum of 12 months before the addition of sec…
rituximabaspirinhydroxychloroquinealprostadilstatinsantiphospholipid syndromeperipheral arterial diseasedry gangreneocclusive artery diseasethromboangiitis obliterans+2 more
…t to standard anticoagulant therapy and requires treatment with rituximab with good effect.…
CalprotectinSystemic lupus erythematosusSLEBühlmann Laboratories AG
…itzerland) according to the manufacturer’s instructions.Results Calprotectin levels were significantly higher in SLE patients compared to th…